PATENT CLAIM ANALYSIS

Application Number: 15873699
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-07
Patent Classification: ["800", "278000"]

Abstract:
Clustered regularly interspaced short palindromic repeats (CRISPR) and the CRISPR associated protein 9 (Cas9) offer an effective way of creating targeted mutagenesis in plants. To alleviate concerns related to genetically modified plants, the present disclosure provides a novel and efficient genome editing system that allows the regeneration of mutant plants without DNA stable integration. This DNA free system utilizes Cas9 mRNA, guide RNA and selectable marker RNA to infect plant protoplasts. After a short period of selection of the transfected cells, non-transgenic plants carrying expected mutations were regenerated. The system offers a way of creating desired mutants without transgenic elements.

Claim (Index 5):
The method of  claim 1  wherein the peptide or protein encoded by the first RNA molecule impairs cellular growth due to intracellular production of a toxic agent as the first selectable property.

Metadata:
- Claim Count in Document: 15.0
- Percentile: 86.0
- Lexical Diversity: 1.41772
- Patent Class: 800.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14885140', '14523799', '14183486', '14258458', '14577997']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.5819612364139084
- 35 USC 102 Novelty (BERT): 0.5044853995116629
- Combined Prediction Score: 0.5742136527236839
- Mean Citation Score: 263.98526400000003
- Max Citation Score: 285.56033
- Similarity Product: 195.8262834755045

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test